© 2019

High-Density Lipoproteins as Biomarkers and Therapeutic Tools

Volume 2. Improvement and Enhancement of HDL and Clinical Applications


Table of contents

  1. Front Matter
    Pages i-xvi
  2. Kyung-Hyun Cho
    Pages 1-76
  3. Kyung-Hyun Cho
    Pages 77-113
  4. Kyung-Hyun Cho
    Pages 115-261
  5. Back Matter
    Pages 263-268

About this book


This book is the second of two volumes that offer a comprehensive, up-to-date account of current knowledge regarding high-density lipoprotein (HDL), the changes that occur in HDL under different conditions, the clinical applications of HDL, and means of enhancing HDL functionality. In this volume, the focus is on the improvement of HDL, enhancement of its functionality, and the use of HDL for therapeutic purposes. In the first section, up-to-date information is provided on such topics as the tumor regression-promoting and antidiabetic activities of reconstituted HDL containing V156K apolipoprotein A-I, the enhancement of HDL effects by high doses of vitamin C, the benefits derived from incorporation of growth hormones 1 and 2 into rHDL, and the biological functions of omega-3 linolenic acid in rHDL. The enhancement of HDL functionality by policosanol and the resultant benefits are thoroughly examined in a separate section. Readers will also find the latest information on clinical applications of HDL. Here, specific topics include the enhancement of adenoviral gene delivery and the delivery of rapamycin. In documenting the latest knowledge in this field, this volume will be of interest to both researchers and clinicians.


HDL, High Density Lipoproteins HDL metabolism HDL-Cholesterol human disease aging process biomarker drug delivery

Authors and affiliations

  1. 1.LipoLabYeungnam UniversityGyeongsan-si, Gyeongsangbuk-doKorea (Republic of)

About the authors

Kyung-Hyun Cho, Professor, LipoLab, Department of Medical Biotechnology, Yeungnam University, Republic of Korea

Bibliographic information